Activated response microglia (ARMs) have been described in an AD mouse model and are characterized by increased expression of genes in MHC type II presentation, inflammatory pathways, and tissue repair; the signature also includes AD risk genes such as APOE. Here, APOE is linked to Alzheimer disease.